In this study, H19EMNVs rescued the hyperglycemia-induced reduction of LncRNA-H19 and proliferation in vitro. All these results implied the potential of LncRNA-H19 as a therapeutic target to treat diabetic wounds by promoting angiogenesis. This evidence concerns the gene H19 and Hyperglycemia.